Business
True cost of becoming a mum highlighted in new data on pay
Femilola MillerMums in England face a “substantial and long-lasting reduction” in earnings after having children, according to new findings from the Office for National Statistics (ONS).
Five years after having their first child, mums’ earnings drop by an average of £1,051 a month compared with their salary one year before having a child.
Mums’ earnings continue to be affected after the births of second and third children.
Rachel Grocott, chief executive of campaign group Pregnant Then Screwed, called the findings “completely abhorrent” and said the impact of the motherhood penalty is “not just unfair – it’s avoidable”.
In the first dataset of its kind, the ONS has looked at the earnings and employment status of mums after having a first, second and third child over an eight-year period from April 2014 to December 2022.
Mums earn £313 a month less on average five years after the birth of their second child, and £689 a month less five years after their third child. Each figure is compared to their salary one year before each birth.
Mums suffer “maximum losses” in the first year after their children are born, when they are more likely to take extended parental leave than dads.
When compared with a mum’s earnings in the year before the birth of a child, the total loss in earnings over five years was:
- £65,618 for a first child
- £26,317 for a second child
- £32,456 for a third child
Femilola Miller, from London, has three children aged seven, five and three.
Before starting a family, she and her husband David had similar salaries, but he now earns £55,000 a year more than her.
Both she and her husband took several months off work after the birth of each child, “but every time my husband went back to work, he got a promotion”.
“Mothers are not compensated even if they return to work full time and are dedicated to their career.”
She believes the motherhood penalty is “engrained in society” and some people enforce the stereotypes “without even realising”, she says, remembering several comments people had made to her about whether she would return to work after having children.
“It was not even a question about what was going to happen to David’s career,” she says.
“I had a career before I had children and I want to carry on working full-time.”
Femilola MillerAlthough the gender pay gap is slowly reducing in the UK, women working full time still earn 7% less than men.
Joeli Brearley, founder of Pregnant Then Screwed, said the motherhood penalty was “a perfect storm of bias, outdated legislation and cultural norms”.
She added “the vast majority” of the gender pay gap is linked to the motherhood penalty, which can be attributed to a number of factors, including:
- unaffordable childcare costs for some families
- an unbalanced parental leave system
- some jobs not offering flexible and part-time working hours
- pregnancy and maternity discrimination
The government has introduced 30 hours a week of funded childcare for working parents and is undertaking a review of parental leave.
New laws also came into force in England, Wales and Scotland last year which give women greater protection against redundancy while pregnant or on maternity leave.
But, according to research from Pregnant then Screwed and Women in Data, up to 74,000 new or expectant mums lose their jobs each year due to pregnancy and maternity discrimination.
Evie JayEvie, 33, from Newcastle, says she feels as though her career is “on hold” until her daughter goes to school.
Evie initially reduced her hours at work when three-year-old Ellie was born, but now works 35 hours a week in the NHS.
She wants to retrain as a therapist, but doing so would mean she could no longer work from home, which isn’t compatible with her childcare arrangements.
She described becoming a mum as “the best thing that’s happened to me, but career-wise, it has been a punishment”.
“You’re expected to be a parent like you don’t work, but work like you haven’t got kids. You can’t win.”
Emma Potts, manager of Market Place Cafe in Stoke-on-Trent, says it is “a really difficult balance” for small businesses like hers to accommodate flexible working, part-time hours or maternity cover.
“We always try to be as supportive as possible, but the reality is that in a small team, flexibility is much harder to manage.”
If staff members were to reduce their hours to part-time, “it would cause real issues”, she says.
“Ultimately, smaller businesses like ours don’t have the luxury of large teams or spare capacity.
“Every shift matters, every deadline matters, and every absence makes a difference.”
Katie Guild, co-founder of Nugget Savings, a business that helps new and expectant parents with financial planning, says the impact of having children can be “shocking” on finances, but there are a number of things parents can do.
This includes checking which benefits you are entitled to and ensuring your employer still contributes to your pension based on your salary as it was before maternity leave.
“Unfortunately, a lot of what we deal with is mothers having difficult situations with their employers and not knowing whether they have a leg to stand on legally,” she says.
“Knowing your rights is really crucial.”
Business
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.
Mike Blake | Reuters
Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible.
The announcement also comes weeks after chief rival Novo Nordisk unveiled additional discounts on the cash prices of its obesity and diabetes drugs.
Starting Monday, cash-paying patients with a valid prescription can get the starting dose of Zepbound vials for as low as $299 per month on LillyDirect, down from a previous price of $349 per month. They can also access the next dose, 5 milligrams, for $399 per month and all other doses for $449 per month, down from $499 per month across those sizes.
Zepbound carries a list price of roughly $1,086 per month. That price point, and spotty insurance coverage for weight loss drugs in the U.S., have been significant barriers to access for some patients.
Eli Lilly’s announcement comes just weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to get and afford. The agreements will cut the prices the government pays for the drugs, introduce Medicare coverage of obesity drugs for the first time for certain patients and offer discounted medicines on the government’s new direct-to-consumer website launching in January, TrumpRx.
But Eli Lilly’s deal with Trump centers around lowering the prices of a different form of Zepbound – a multi-dose pen – after it wins Food and Drug Administration approval.
That means Eli Lilly’s Monday announcement around cutting prices on the existing single-dose vials could allow more patients to get discounted treatments more quickly.
“We will keep working to provide more options — expanding choices for delivery devices and creating new pathways for access — so more people can get the medicines they need,” said Ilya Yuffa, president of Lilly USA and global customer capabilities, in a statement.
Eli Lilly’s stock, which has climbed more than 36% this year, fell nearly 2% on Monday. Its meteoric rise due to the success of Zepbound and its diabetes injection Mounjaro vaulted it to becoming the first health-care company to hit a $1 trillion market value last month. Though cutting prices means lower revenue per medication sold, Eli Lilly’s sales — and shares — have continued to soar through past pricing announcements as demand balloons.
With single-dose vials, patients need to use a syringe and needle to draw up the medicine and inject it into themselves. Eli Lilly first introduced that form of Zepbound in August 2024.
It’s unclear how many patients are currently using single-dose vials of Zepbound. But Eli Lilly previously said that direct-to-consumer sales now account for more than a third of new prescriptions of Zepbound.
Novo Nordisk earlier this month lowered the price of its obesity drug Wegovy and diabetes treatment Ozempic for existing cash-paying patients to $349 per month from $499 per month. That excludes the highest dose of Ozempic.
The company also launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment.
Business
OBR chairman resigns over Budget leak
The chairman of the Office for Budget Responsibility (OBR) has resigned over the early publication of the watchdog’s forecasts.
Richard Hughes said he was resigning to allow the OBR to “quickly move on from this regrettable incident”.
His resignation follows publication of a report that described the leak as “the worst failure in the 15-year history of the OBR” and strongly criticised the watchdog’s processes for protecting sensitive information.
In a letter to the Chancellor and the chairwoman of the Commons Treasury Committee, Mr Hughes said he took “full responsibility” for “the shortcomings identified in the report”.
He said: “By implementing the recommendations in this report, I am certain the OBR can quickly regain and restore the confidence and esteem that it has earned through 15 years of rigorous, independent economic analysis.”
Mr Hughes has served as chairman of the OBR since 2020 and was reappointed to the job for a second five-year term in July this year.
Speaking in the Commons as the news of the resignation broke, Chief Secretary to the Treasury James Murray offered the Government’s thanks to Mr Hughes “for his dedication to public service”.
Later, the Chancellor herself offered her thanks for Mr Hughes’ “many years of public service”, adding: “This Government is committed to protecting the independence of the OBR and the integrity of our fiscal framework and institutions.”
Conservative leader Kemi Badenoch accused the Chancellor of using Mr Hughes as a “human shield” and called on Rachel Reeves to resign.
Liberal Democrat Treasury spokeswoman Daisy Cooper said Mr Hughes was “a dedicated public servant” who had “rightly taken responsibility for a failure on his watch”, adding the OBR needed to learn from its “catastrophic error”.
Treasury Committee chairwoman Dame Meg Hillier also thanked Mr Hughes, saying: “I commend his decision to take full responsibility for the incident and I wish him well for the future.”
The Treasury said it would begin the process of finding a replacement for Mr Hughes “in the coming weeks”.
The OBR launched an investigation after official forecasts were uploaded to the watchdog’s website, releasing details of the Budget almost an hour early.
In a report published on Monday, the OBR said the leak had been “seriously disruptive to the Chancellor, who had every right to expect that the (forecasts) would not be publicly available until she sat down at the end of her Budget speech”.
Noting Mr Hughes had already “rightly” apologised for the leak, the report said it was “not a case of intentional leakage” or a matter of pressing publish too early.
The OBR said it was caused by two errors linked to the WordPress publishing site it used.
The report into the incident said that, while it knew web addresses for its files follow a pattern, it assumed “the protections provided” by WordPress “would ensure it could not be accessed”.
But two configuration errors were the technical causes of the premature access.
The forecast for the last spring statement in March was also “accessed prematurely” on one occasion, the report noted, but concluded that no activity appeared to have been taken as a result and the most likely explanation is “benign”.
The report recommended a review of the watchdog’s processes for publishing such documents.
“To rebuild trust, the leadership of the OBR must take immediate steps to change completely the publication arrangements for the two important and time-sensitive documents containing the results of its biannual forecasts that it publishes in a normal year, and review arrangements for all other publications,” the report said.
One option would be for the watchdog to use the Government’s digital architecture but publish when it wants.
Another would be to have the Treasury publish the forecasts for the Budget and spring statement, but this would only work if safeguards for “real and perceived independence” could be put in place.
There may need to be an interim solution, the report noted, but said new arrangements must be in place in time for the next statement in spring 2026.
Business
OGRA Announces LPG Price Increase for December – SUCH TV
The Oil and Gas Regulatory Authority (OGRA) has approved a fresh increase in the price of liquefied petroleum gas (LPG), raising the cost for both domestic consumers and commercial users.
According to the notification issued, the LPG price has been increased by Rs7.39 per kilogram, setting the new rate at Rs209 per kg for December. As a result, the price of a domestic LPG cylinder has risen by Rs87.21, bringing the new price to Rs2,466.10.
In November, the price of LPG stood at Rs201 per kg, while the domestic cylinder was priced at Rs2,378.89.
The latest price hike is expected to put additional pressure on households already grappling with rising living costs nationwide.
-
Sports1 week agoWATCH: Ronaldo scores spectacular bicycle kick
-
Entertainment1 week agoWelcome to Derry’ episode 5 delivers shocking twist
-
Politics1 week agoWashington and Kyiv Stress Any Peace Deal Must Fully Respect Ukraine’s Sovereignty
-
Business1 week agoKey economic data and trends that will shape Rachel Reeves’ Budget
-
Tech6 days agoWake Up—the Best Black Friday Mattress Sales Are Here
-
Politics1 week ago53,000 Sikhs vote in Ottawa Khalistan Referendum amid Carney-Modi trade talks scrutiny
-
Fashion1 week agoCanada’s Lululemon unveils team Canada kit for Milano Cortina 2026
-
Tech1 day agoGet Your Steps In From Your Home Office With This Walking Pad—On Sale This Week

